Negri et al
Compounding pharmacies, regulated by the FDA and state boards, create personalized formulations under stringent quality controls, ensuring purity, accurate dosing, and sterilityreducing risks of contamination or substandard products.[41][42][43] These are tailored for human use under medical supervision, often with third-party testing
The button purple is just the standard design across all pens
While clinical trials are ongoing, a study published in Alzheimers & Dementia in October 2024 found that people with Type 2 diabetes who used semaglutide (the active ingredient in Ozempic, Wegovy, and Rybelsus) had a lower risk of a first-time diagnosis of Alzheimers disease, compared to people who used insulin, other GLP-1s, or other diabetes medicines
The effect of medications on obesity-related complications is heterogeneous and not always proportional to the degree of total weight loss, potentially reflecting direct pharmacological actions beyond weight reduction alone